NUVB
NYSE · Pharmaceuticals
Nuvation Bio Inc
$5.56
+0.23 (+4.32%)
Open$5.44
Previous Close$5.33
Day High$5.58
Day Low$5.33
52W High$9.75
52W Low$1.58
Volume—
Avg Volume4.94M
Market Cap1.94B
P/E Ratio—
EPS$-0.43
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+677.3% upside
Current
$5.56
$5.56
Target
$43.22
$43.22
$30.63
$43.22 avg
$69.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 67.10M | 781.90M | 798.00M |
| Net Income | -218,234,584 | 141.36M | 136.11M |
| Profit Margin | -325.3% | 18.1% | 17.1% |
| EBITDA | -225,374,290 | 195.91M | 227.47M |
| Free Cash Flow | — | 85.45M | 83.04M |
| Rev Growth | — | +23.6% | -6.7% |
| Debt/Equity | 0.68 | 0.84 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |